Safety guide · Wegovy label rev. 06/2026
Wegovy Side Effects, Rate by Rate: Pen, HD and Pill
Nausea is the most common Wegovy side effect: 44% on the 2.4 mg pen vs 16% on placebo, and 39% on 7.2 mg. Most stomach effects show up while the dose is stepped up.
- Top 5 are all digestive
- 6.8% stopped for side effects vs 3.2%
- Boxed warning: thyroid C-cell tumors
- Pill: severe GI 2% vs 0%
We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure
Chia Health
Our #1 pick for GLP-1 weight loss online
- One monthly price: clinician, medication and free shipping included
- Semaglutide or tirzepatide, as a weekly injection or a daily tablet
- No insurance needed; HSA/FSA and Klarna accepted
Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure
$212.89 first month, then $349/mo
6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.
01 Most common
Common Wegovy Side Effects on the 2.4 mg Pen
Wegovy is semaglutide, a once-weekly injection (and a daily tablet) for weight reduction and heart-risk reduction. The label lists 19 reactions seen in at least 2% of adults on the 2.4 mg pen and more often than on placebo. Most are digestive, which fits how semaglutide works: it slows how fast the stomach empties.
| Side effect | Placebo (N=1,261) | Wegovy 2.4 mg (N=2,116) |
|---|---|---|
| Nausea | 16% | 44% |
| Diarrhea | 16% | 30% |
| Vomiting | 6% | 24% |
| Constipation | 11% | 24% |
| Abdominal pain | 10% | 20% |
| Headache | 10% | 14% |
| Fatigue | 5% | 11% |
| Dyspepsia (indigestion) | 3% | 9% |
| Dizziness | 4% | 8% |
| Abdominal distension | 5% | 7% |
| Belching | <1% | 7% |
| Low blood sugar, type 2 diabetes only | 2% | 6% |
| Gas (flatulence) | 4% | 6% |
| Hair loss | 1% | 3% |
Label 6.1, Table 3 Also in the table: gastroenteritis 6% vs 4%, reflux 5% vs 3%, gastritis 4% vs 1%, viral gastroenteritis 4% vs 3%, dysesthesia 2% vs 1%. Vomiting is 24% in Table 3 and 25% in the label's text summary of stomach reactions; this page uses the table.
Across the three trials, 6.8% on Wegovy and 3.2% on placebo stopped for side effects, most often for nausea (1.8% vs 0.2%), vomiting (1.2% vs 0%) and diarrhea (0.7% vs 0.1%). For scale, the same label reports 14.9% average weight loss at week 68 in the main pen trial (STEP 1) vs 2.4% on placebo.
02 Wegovy HD
Wegovy HD 7.2 mg Side Effects vs 2.4 mg
Wegovy HD is the 7.2 mg weekly dose. Its safety data come from two 72-week trials with 1,311 adults on 7.2 mg, 304 on 2.4 mg and 303 on placebo. The chart shows reactions that were at least 2% and more common on 7.2 mg than on both other arms.
Label 6.1, Table 4
- Dysesthesia is the HD signal. Burning, tingling or sensitive skin: 22% on 7.2 mg vs 6% on 2.4 mg and 0.3% on placebo. Of 288 people who had it on 7.2 mg, 2% stopped, 8% paused and 23% lowered the dose; 18% had not recovered by the end of the trial. Of 38 who recovered and went back to 7.2 mg, 17 (45%) had it again.
- Stopping was the same on both doses. 5% on 7.2 mg, 5% on 2.4 mg and 2% on placebo stopped because of side effects, mostly stomach-related (3%, 3%, 0.3%).
Weight loss in the same trial program: 18.8% on 7.2 mg vs 15.5% on 2.4 mg and 3.9% on placebo at week 72. Dosing and price: Wegovy HD 7.2 mg.
03 Wegovy pill
Wegovy Pill (25 mg Tablet) Side Effects vs the Pen
The label has no separate side-effect table for the tablet. It says the types and frequency of common reactions on 25 mg were similar to the pen's Table 3. The tablet trial (OASIS 4) had 204 adults on 25 mg for 64 weeks and excluded people with type 2 diabetes. Where the label splits the numbers, they are below.
The tablet is taken on an empty stomach in the morning with up to 4 ounces of plain water; wait at least 30 minutes before eating, drinking or taking other oral medicines. Details: Wegovy pill and Wegovy pill vs injection.
04 Timing
When Wegovy Side Effects Happen and How Long They Last
- 1
Weeks 1 to 4. 0.25 mg pen once a week, or 1.5 mg tablet once a day. Mild nausea or fullness is the usual report. Smaller meals and steady fluids help.
- 2
Each dose step. The pen goes 0.5 mg, 1 mg, 1.7 mg, then 2.4 mg, one step every 4 weeks. The label says stomach reactions were most often reported during escalation, so expect a flare around a step.
- 3
If a step is not tolerated. The label lets the prescriber delay the next increase by 4 weeks. That is a clinician decision, not one to make alone.
- 4
Maintenance. 2.4 mg pen (or 7.2 mg HD) or 25 mg tablet. The label gives no day count for how long nausea lasts, so this page does not claim one.
- 5
Effects that will not settle. Vomiting or diarrhea that keeps going risks dehydration and kidney injury. Call your prescriber (see below).
Label 2.2, 2.3, 6.1
Food and timing tips beyond the label: how to handle GLP-1 nausea. Every dose step: Wegovy dosage.
05 Warnings
Serious Wegovy Warnings, With the Numbers
These are the warnings in section 5 of the label. Each is uncommon; each has a symptom pattern worth knowing.
Pancreatitis
Severe belly pain that will not go away, sometimes through to the back, with or without vomiting. Confirmed in 4 Wegovy patients (0.2 per 100 patient-years) vs 1 on placebo. Stop Wegovy if suspected. 5.2, 6.1
Gallbladder disease
Upper belly pain, fever, yellow skin or eyes, clay-colored stools. Gallstones 1.6% on the pen vs 0.7%, 2.5% on the tablet vs 1%; cholecystitis 0.6% vs 0.2%. 5.3, 6.1
Severe stomach reactions
4.1% on the pen vs 0.9%; 2% on the tablet vs 0%. Not recommended with severe gastroparesis. Ileus, bowel obstruction and fecal impaction appear in postmarketing reports. 5.6, 6.2
Kidney injury
7 adults on Wegovy (0.4 per 100 patient-years) vs 4 on placebo (0.2), some linked to vomiting, diarrhea or dehydration. Keep fluids up. 5.5, 6.1
Low blood sugar
Mainly in type 2 diabetes: below 54 mg/dL in 6.2% on the pen vs 2.5% on placebo, and higher with a sulfonylurea or insulin. 5.4, 6.1
Allergic reactions
Anaphylaxis and angioedema have been reported. Stop Wegovy and get help right away. 5.7
Eyes in type 2 diabetes
Diabetic retinopathy in 4% on the pen vs 2.7% on placebo in the diabetes trial. Fast sugar improvement can briefly worsen it. 5.8, 6.1
Heart rate
Average rise of 1 to 4 beats a minute; a peak rise of 20 or more in 26% vs 16% on placebo. Report a racing heart at rest. 5.9, 6.1
Surgery and sedation
Rare reports of food aspirated into the lungs under anesthesia. Tell your surgeon and anesthesia team you take Wegovy. 5.10
Never share a pen
A Wegovy FlexTouch pen is for one person only, even with a new needle, because of infection risk. 5.11
06 Boxed warning
Boxed Warning: Thyroid C-Cell Tumors
Wegovy carries the FDA's boxed warning for thyroid C-cell tumors. In rats and mice, semaglutide caused these tumors at clinically relevant exposures. The label says it is unknown whether Wegovy causes them, including medullary thyroid carcinoma (MTC), in people.
- Do not use Wegovy with a personal or family history of MTC, or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Report a lump in the neck, trouble swallowing, shortness of breath or hoarseness that does not go away.
Routine calcitonin tests or thyroid ultrasound are of uncertain value for early detection, per the label. (Boxed Warning, 4, 5.1)
07 Red flags
When to Call a Doctor or Get Emergency Help
Get help right away
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, severe rash, fainting (stop Wegovy)
- Severe belly pain that will not go away, with or without vomiting, sometimes felt in the back (stop Wegovy)
- Too much Wegovy: severe nausea, vomiting or low blood sugar. Poison Help 1-800-222-1222 or the nearest ER
Call your prescriber soon
- Nausea, vomiting or diarrhea that does not go away
- Upper belly pain, fever, yellow skin or eyes, clay-colored stools
- Low blood sugar signs with type 2 diabetes: shakiness, sweating, confusion, fast heartbeat
- Vision changes if you have type 2 diabetes
- A racing heart at rest that lasts several minutes
- A neck lump, trouble swallowing, lasting hoarseness
- Any planned surgery, colonoscopy or sedation
Report side effects to the FDA at 1-800-FDA-1088 (MedWatch). A clinician who knows your history should decide about dose changes or stopping. Medication Guide
Ro prescribes the Wegovy pen, Wegovy HD and the Wegovy pill, with clinician follow-up for side-effect questions and dose changes during titration.
See Wegovy eligibility with Ro08 Other effects
Other Side Effects the Label Lists
- Hair loss
- 2.4 mg pen: 3.3% (4% of women, 0.9% of men) vs 1% on placebo. 7.2 mg: 5.8% (8.4% of women, 0.2% of men). The label links it to weight reduction. 6.1
- Low blood pressure, fainting
- hypotension 1.3% vs 0.4%; fainting 0.8% vs 0.2%, more often with blood pressure medicines. 6.1
- Appendicitis
- 10 patients (0.5%) vs 2 (0.2%) on placebo. 6.1
- Injection-site reactions
- 1.4% vs 1% (itching, redness, irritation). 6.1
- Taste change
- dysgeusia 1.7% vs 0.5%. 6.1
- Fractures
- in the heart-outcomes trial, hip and pelvis fractures in women: 1% (24 of 2,448) vs 0.2% (5 of 2,424). 6.1
- Kidney stones
- urolithiasis 1.2% vs 0.8% in the heart-outcomes trial. 6.1
- Lab changes
- amylase up 15% to 16% and lipase up 39% on average; meaning unknown without other signs of pancreatitis. 6.1
- Pregnancy
- stop Wegovy at least 2 months before a planned pregnancy. Pregnancy registry: 1-877-390-2760. 8.1
The years-long picture (heart-outcomes trial, regain after stopping): GLP-1 long-term side effects. Same molecule, diabetes brand: Ozempic side effects. Tirzepatide for comparison: Mounjaro side effects.
09 Label change
FDA Removed the Suicidality Warning in January 2026
Jan 13, 2026
The FDA asked the makers of Wegovy, Saxenda and Zepbound to remove the suicidal behavior and ideation warning after its review found no increased risk, including a meta-analysis of 91 placebo-controlled trials with 107,910 participants.
Label rev. 06/2026
The Wegovy label lists "Suicidal Behavior and Ideation (Removed) 01/2026". The thyroid boxed warning is unchanged.
Older pages that still describe a suicidality warning on Wegovy are out of date. Mood changes are still worth mentioning to your clinician.
10 FAQ
Wegovy Side Effects FAQ
What are the most common Wegovy side effects?
Does the Wegovy pill have the same side effects as the pen?
Are Wegovy HD (7.2 mg) side effects worse?
Does Wegovy cause hair loss?
Can Wegovy cause thyroid cancer?
When should I stop Wegovy and call a doctor?
Does Wegovy still have a suicide warning?
All GLP-1 safety info in one place: GLP-1 side effects and safety hub.
Prices for every Wegovy form: Wegovy cost. Brand overview: Wegovy guide.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.
Last updated Oct 29, 2026 · Side-effect rates checked against the Wegovy label (injection and tablets, rev. 06/2026). This page is not medical advice; talk to your healthcare provider about your own risks.
References
- Wegovy (semaglutide) injection and tablets, Prescribing Information and Medication Guide, revised 06/2026, checked 2026-10-20, Novo Nordisk, 2026
- FDA requests removal of suicidal behavior and ideation warning from GLP-1 receptor agonist medications, Jan 13, 2026, U.S. FDA, 2026
- MedWatch: The FDA Safety Information and Adverse Event Reporting Program, U.S. FDA, 2026
- Poison Help line, HRSA, 2026